Overview
A pharmaceutical manufacturing unit located in Baddi, established in 2020, is available for sale or joint venture. The facility has a built-up area of 36,100 sq. ft. and holds a WHO-GMP license valid until 2026, ensuring compliance with international quality standards. The unit specializes in the production of tablets and capsules, with a current capacity of 30 lakh tablets and 12 lakh capsules per day, operating in three shifts. We provide contract manufacturing services to 10 companies and have established a strong export presence in Yemen, Myanmar, and Congo. Our commitment to quality, efficiency, and timely delivery has made us a trusted partner in the pharmaceutical industry. To meet growing demand and expand our capabilities, we are seeking funds for further expansion. We are also open to a full sale, offering an excellent opportunity for investors or companies looking to enter or strengthen their position in the pharmaceutical sector. With modern infrastructure, robust manufacturing capacity, and an established client base, this unit presents significant growth potential in both domestic and international markets.
Business Details
Describe Property
N.A
Competition / Market
Yes we have some competition
Products & Services
The unit specializes in the production of tablets and capsules, with a current capacity of 30 lakh tablets and 12 lakh capsules per day, operating in three shifts. We provide contract manufacturing services to 10 companies and have established a strong export presence in Yemen, Myanmar, and Congo.
Growth Potential
Very High
Reason For Sale
Personal Reason
Financial Details
How the Acquisition Process Works
- 01Contact SellerContact Seller
- 02Teaser/Information MemorandumTeaser/Information Memorandum
- 03Valuation ReportValuation Report
- 04FinancialsFinancials
- 05Schedule an Advisory MeetingBook Your Consultation